During the past decade, Deaconess Clinic Downtown conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 29 clinical trials were completed, i.e. on average, 67.4% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 23 clinical trials were completed. i.e. 1150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Deaconess Clinic Downtown" #1 sponsor was "National Cancer Institute (NCI)" with 19 trials, followed by "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "SWOG Cancer Research Network" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored and "Pfizer" with 5 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Deaconess Clinic Downtown" #1 collaborator was "National Cancer Institute (NCI)" with 25 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "Athenex, Inc." with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Deaconess Clinic Downtown" are "Invasive Breast Carcinoma" (4 trials), "Stage IIIA Breast Cancer" (4 trials), "Psoriasis" (3 trials), "Recurrent Squamous Cell Lung Carcinoma" (3 trials) and "Stage II Breast Cancer" (3 trials). Many other conditions were trialed in "Deaconess Clinic Downtown" in a lesser frequency.

Most popular intervention types in "Deaconess Clinic Downtown" are "Drug" (50 trials), "Other" (30 trials), "Biological" (18 trials), "Procedure" (15 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (17 trials), "Quality-of-Life Assessment" (9 trials), "Biospecimen Collection" (8 trials), "Computed Tomography" (8 trials) and "Nivolumab" (8 trials). Other intervention names were less common.

The vast majority of trials in "Deaconess Clinic Downtown" are 55 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Deaconess Clinic Downtown". undefined are not yet recruiting, 7 are recruiting, 30 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Deaconess Clinic Downtown, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Deaconess Clinic Downtown, 1 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".